The principles that govern breast surgery in triple negative breast cancer are similar to the ones that govern surgery for other types of breast cancers. Surgery is still the cornerstone of treatment for all of these tumors and an integral part in all treatment strategies.
The vast majority of patients with a triple negative breast cancer will benefit from chemotherapy. It is only those patients with severe additional medical conditions or extraordinarily small cancers or a very advanced age where chemotherapy may not be of benefit.
Integrative medicine is the practice of medicine that reaffirms the importance of the relationship between practitioner and patient, focuses on the whole person, is informed by evidence, and makes use of all appropriate therapeutic approaches, healthcare professionals, and disciplines to achieve optimal health and healing.
Finally, the era of immunotherapy has arrived in triple negative breast cancer. Some patients with metastatic disease will benefit from a group of immunotherapeutic agents called Check Point Inhibitors.